KRYS

KRYS

USD

Krystal Biotech Inc. Common Stock

$203.260+7.795 (3.988%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$195.465

Haut

$212.980

Bas

$195.465

Volume

0.66M

Fondamentaux de l'Entreprise

Capitalisation Boursière

5.9B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.32M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $122.8Actuel $203.260Haut $212.98

Actualités Connexes

Analyst Upgrades

Citigroup Maintains Neutral on Krystal Biotech, Raises Price Target to $198

Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech with a Neutral and raises the price target from $166 to $198.

Voir plus
Citigroup Maintains Neutral on Krystal Biotech, Raises Price Target to $198
Analyst Upgrades

Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $220

Chardan Capital analyst Geulah Livshits maintains Krystal Biotech with a Buy and raises the price target from $216 to $220.

Voir plus
Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $220
GlobeNewswire

Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results

$97.8 million in 3Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and

Voir plus
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results